NEW YORK, Dec. 12 — Berlin’s Max Delbruck Center for Molecular Medicine bought a high-throughput genotyping system from Pyrosequencing, the company announced today.

The Berlin institution’s Gene Mapping Center and Department of Molecular Genetics will use Pyrosequencing’s Preferred Technology Program for SNP analysis in research into the genetics of complex diseases. Researchers will also collaborate with Pyrosequencing to continue to develop and expand the capacity of the system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.